Quest Diagnostics Incorporated
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Quest Diagnostics Incorporated generated cash of $1,272,000,000, which is less than the previous year. Cash used in financing activities reached the amount of $160,000,000 last year. Net change in cash is therefore $371,000,000.
Cash Flow
| 2014 | 938M | -1.02B | 92M |
|---|---|---|---|
| 2015 | 810M | -362M | -507M |
| 2016 | 1.06B | -152M | -691M |
| 2017 | 1.17B | -805M | -592M |
| 2018 | 1.2B | -801M | -401M |
| 2019 | 1.24B | -411M | 225M |
| 2020 | 2.00B | -772M | -1.26B |
| 2021 | 2.23B | 21M | -2.54B |
| 2022 | 1.71B | -543M | -1.73B |
| 2023 | 1.27B | -1.06B | 160M |
DGX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 315M | 872M | 1.15B | 1.19B | 135M | 137M | 359M | 133M | 192M | 187M |
Operating activities | ||||||||||
Net income | 908M | 1.01B | 2.08B | 1.49B | 906M | 788M | 824M | 696M | 753M | 592M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 439M | 437M | 408M | 361M | 329M | 309M | 270M | 249M | 304M | 314M |
Stock-based compensation expense | 77M | 77M | 79M | 97M | 56M | 61M | 79M | 69M | 52M | 51M |
| Deferred income tax benefit | 77M | 77M | 79M | 97M | 56M | 61M | 79M | 69M | 52M | 51M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -15M | 246M | 81M | -455M | -63M | -65M | -298M | -343M | -262M | -312M |
Inventories | 0 | 0 | -20M | 0 | 29M | 4M | 16M | 42M | -41M | -84M |
Accounts payable | -55M | -149M | 35M | 452M | 73M | -19M | -8M | 56M | -31M | 68M |
Cash generated by operating activities | 1.27B | 1.71B | 2.23B | 2.00B | 1.24B | 1.2B | 1.17B | 1.06B | 810M | 938M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -5M | -3M | -27M | -44M | 383M | 252M | 293M | 263M | 308M |
Investments In Property Plant And Equipment | -408M | -404M | -403M | -418M | -400M | -383M | -252M | -293M | -263M | -308M |
Acquisitions Net | -611M | -144M | 424M | -330M | -58M | -419M | -555M | 131M | -100M | -728M |
Cash generated by investing activities | -1.06B | -543M | 21M | -772M | -411M | -801M | -805M | -152M | -362M | -1.02B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 129M | 938M | 0 | 2.18B | 0 | 1.94B | 0 | 2.09B |
Payments for dividends | -314M | -305M | -309M | -297M | -286M | -266M | -247M | -223M | -212M | -187M |
Repurchases of common stock | -275M | -1.40B | -2.19B | -325M | -353M | -322M | -465M | -590M | -224M | -132M |
Repayments of term debt | 748M | -2M | -2M | -1.55B | 832M | -1.96B | 23M | -1.72B | -84M | -1.64B |
Cash used in financing activities | 160M | -1.73B | -2.54B | -1.26B | 225M | -401M | -592M | -691M | -507M | 92M |
Net Change In Cash | 371M | -557M | -286M | -34M | 1.05B | -2M | -222M | 226M | -59M | 5M |
Cash at end of period | 686M | 315M | 872M | 1.15B | 1.19B | 135M | 137M | 359M | 133M | 192M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |